Literature DB >> 10973595

Multiple opioid receptors mediate feeding elicited by mu and delta opioid receptor subtype agonists in the nucleus accumbens shell in rats.

A Ragnauth1, M Moroz, R J Bodnar.   

Abstract

The nucleus accumbens, and particularly its shell region, is a critical site at which feeding responses can be elicited following direct administration of opiate drugs as well as micro-selective and delta-selective, but not kappa-selective opioid receptor subtype agonists. In contrast to observations of selective and receptor-specific opioid antagonist effects upon corresponding agonist-induced actions in analgesic studies, ventricular administration of opioid receptor subtype antagonists blocks feeding induced by multiple opioid receptor subtype agonists. The present study examined whether feeding responses elicited by either putative mu ([D-Ala(2), NMe-Phe(4), Gly-ol(5)]-enkephalin (DAMGO)), delta(1) ([D-Pen(2), D-Pen(5)]-enkephalin (DPDPE)) or delta(2) ([D-Ala(2), Glu(4)]-deltorphin (Deltorphin)) opioid receptor subtype agonists administered into the nucleus accumbens shell were altered by accumbens pretreatment with either selective mu (beta-funaltrexamine), mu(1) (naloxonazine), delta(1) ([D-Ala(2), Leu(5), Cys(6)]-enkephalin (DALCE)), delta(2) (naltrindole isothiocyanate) or kappa(1) (nor-binaltorphamine) opioid receptor subtype antagonists. Similar magnitudes and durations of feeding responses were elicited by bilateral accumbens administration of either DAMGO (2.5 microg), DPDPE (5 microg) or Deltorphin (5 microg). DAMGO-induced feeding in the nucleus accumbens shell was significantly reduced by accumbens pretreatment of mu, delta(1), delta(2) and kappa(1), but not mu(1) opioid receptor subtype antagonists. DPDPE-induced feeding in the accumbens was significantly reduced by accumbens pretreatment of mu, delta(1), delta(2) and kappa(1), but not mu(1) opioid receptor subtype antagonists. Deltorphin-induced feeding in the accumbens was largely unaffected by accumbens delta(2) antagonist pretreatment, and was significantly enhanced by accumbens mu or kappa(1) antagonist pretreatment. These data indicate different opioid pharmacological profiles for feeding induced by putative mu, delta(1) and delta(2) opioid agonists in the nucleus accumbens shell, as well as the participation of multiple opioid receptor subtypes in the elicitation and maintenance of feeding by these agonists in the nucleus accumbens shell.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10973595     DOI: 10.1016/s0006-8993(00)02631-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  22 in total

1.  A naloxonazine sensitive (mu1 receptor) mechanism in the parabrachial nucleus modulates eating.

Authors:  Nayla N Chaijale; Vincent J Aloyo; Kenny J Simansky
Journal:  Brain Res       Date:  2008-09-04       Impact factor: 3.252

2.  Opioid hedonic hotspot in nucleus accumbens shell: mu, delta, and kappa maps for enhancement of sweetness "liking" and "wanting".

Authors:  Daniel C Castro; Kent C Berridge
Journal:  J Neurosci       Date:  2014-03-19       Impact factor: 6.167

3.  Intra-accumbens infusion of a muscarinic antagonist reduces food intake without altering the incentive properties of food-associated cues.

Authors:  Michelle L Perry; Matthew E Andrzejewski; Susan M Bushek; Brian A Baldo
Journal:  Behav Neurosci       Date:  2010-02       Impact factor: 1.912

4.  Prolonged morphine treatment selectively increases membrane recruitment of delta-opioid receptors in mouse basal ganglia.

Authors:  Anna Lisa Lucido; Anne Morinville; Louis Gendron; Thomas Stroh; Alain Beaudet
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

5.  Orexin in Rostral Hotspot of Nucleus Accumbens Enhances Sucrose 'Liking' and Intake but Scopolamine in Caudal Shell Shifts 'Liking' Toward 'Disgust' and 'Fear'.

Authors:  Daniel C Castro; Rachel A Terry; Kent C Berridge
Journal:  Neuropsychopharmacology       Date:  2016-01-20       Impact factor: 7.853

6.  Reversible suppression of food reward behavior by chronic mu-opioid receptor antagonism in the nucleus accumbens.

Authors:  A C Shin; P J Pistell; C B Phifer; H R Berthoud
Journal:  Neuroscience       Date:  2010-07-27       Impact factor: 3.590

7.  Dopamine or opioid stimulation of nucleus accumbens similarly amplify cue-triggered 'wanting' for reward: entire core and medial shell mapped as substrates for PIT enhancement.

Authors:  Susana Peciña; Kent C Berridge
Journal:  Eur J Neurosci       Date:  2013-03-17       Impact factor: 3.386

8.  Chronic suppression of μ-opioid receptor signaling in the nucleus accumbens attenuates development of diet-induced obesity in rats.

Authors:  N R Lenard; H Zheng; H-R Berthoud
Journal:  Int J Obes (Lond)       Date:  2010-01-12       Impact factor: 5.095

9.  Muscarinic receptor antagonism causes a functional alteration in nucleus accumbens mu-opiate-mediated feeding behavior.

Authors:  Michelle L Perry; Brian A Baldo; Matthew E Andrzejewski; Ann E Kelley
Journal:  Behav Brain Res       Date:  2008-08-12       Impact factor: 3.332

10.  The role of amygdalar mu-opioid receptors in anxiety-related responses in two rat models.

Authors:  Marlene A Wilson; Lorain Junor
Journal:  Neuropsychopharmacology       Date:  2008-01-23       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.